RESEARCH TRIANGLE PARK, N.C. - Saturday, June 22nd 2013 [ME NewsWire]
DIA 2013
(BUSINESS WIRE)-- Quintiles today announced new functionality that improves laboratory management for investigator sites, delivered by its award-winning Quintiles Infosario® technology platform. Infosario seamlessly combines data, processes and Quintiles’ therapeutic expertise to enable faster, better-informed decisions across the drug development lifecycle. With Infosario, investigators and site personnel now have the ability to order tests, track samples and view results within one secure, online portal.
“The investigators working with Quintiles’ Global Laboratory network can now experience the benefits of streamlined communications, improved data accuracy and accelerated laboratory tests results,” said Thomas Wollman, Senior Vice President, Quintiles Global Laboratories and Cardiac Safety Services. “Our customers and investigators view the Infosario portal as a significant step forward in improving the speed and quality of laboratory management. This is another example of how we partner with our customers to improve their probability of success.”
The portal puts timely laboratory data at the fingertips of investigators, offering greater transparency and efficiency to tighten study timelines and improve patient safety through enhanced data quality. Investigators and site personnel can process electronic requisitions, review reports and respond to queries in an interactive format that cuts hours out of the process. The new functionality offers:
Improved data quality through electronic requisitions and simplified medical reporting resolutions
Improved sample tracking and traceability through electronic sample tracking
Improved data consistency and fewer queries through the availability of online Standard Operating Procedures (SOPs) and training
Reduced query resolution time through email alerts for unviewed medical reports or unanswered queries
More than a quarter of Quintiles’ investigators currently have access to the Infosario portal, and new functionality across Quintiles’ laboratory and clinical development services will be released in the near future to expand the platform to Quintiles’ entire network of more than 175,000 investigators. In an effort to continuously improve Infosario to meet customers’ needs, Quintiles is introducing enhancements in the coming months, including secure document exchange, investigator profile registrations and online training capabilities.
According to Michelle Kopfinger, an investigator site coordinator, “Quintiles is making proactive changes to help make lab management from a site perspective less burdensome. All of the lab reports are at the tip of your fingers and the data clarifications are resolved quicker through the system. It’s a great tool for managing lab reports.”
This announcement comes on the heels of Quintiles receiving the 2013 Informatica Innovation Award for “Enterprise Data Integration” for Infosario’s pioneering efforts to integrate clinical research and healthcare data across numerous institutions and at a scale never before accomplished in the biopharmaceutical industry. For more information, view the Infosario portal fact sheet and website. Demonstrations of Infosario will be available at the Drug Information Association (DIA) Annual Meeting on June 24-27 in Boston, Mass.
About Quintiles
Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 27,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Mari Mansfield, + 1-919-998-2639
Media Relations
mari.mansfield@quintiles.com
Mobile: +1-919-259-3298
Karl Deonanan, +1-919-998-2789
Investor Relations
InvestorRelations@quintiles.com
Permalink: http://www.me-newswire.net/news/7733/en
No comments:
Post a Comment